Clinical Trial
Macular Degeneration Clinical Trial 20213033
[LCID Study Number: 20213033]
A Study to Genetically Define Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
The purpose of this study is to evaluate subjects with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) by sequencing selected genes associated with AMD.
Disease/Condition: Macular Degeneration
Department: Ophthalmology
Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody